Frontlight ResearchEarly access
Triple-negative breast cancer trials in Indonesia
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleThe Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer
- Where
- Jakarta Pusat
- Age
- 18 years and over
- People
- 26
- Run by
- Universitas Indonesia
See details and how to joinNCT05550415 - No phaseTaking peoplePredicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
- Where
- Jakarta
- Age
- 18 years and over
- People
- 125 worldwide
- Run by
- Gene Solutions
See details and how to joinNCT06087120